Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2026-01-04 @ 12:01 AM
Study NCT ID:
NCT06967961
Status:
RECRUITING
Last Update Posted:
2025-07-29
First Post:
2025-05-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Sponsor:
Institut Claudius Regaud
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2029-07-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-07-23
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-05
First Submit QC Date:
None
Study First Post Date:
2025-05-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-28
Last Update Post Date:
2025-07-29
Last Update Post Date Type:
ACTUAL